28 , 29 However, the risk of venous thromboembolism may be significant even in patients with focal segmental glomerulosclerosis, 30 – 32 and the low rate of reported adverse events with therapeutic anticoagulation as well as our patient’s markedly decreased serum Alb levels encouraged us to pursue pharmacological prophylaxis as practiced in the ordinary clinical setti
← all excerpts
Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury.
1
—
—